Investors might want to bet on Black Diamond (BDTX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
Black Diamond Therapeutics shows promise with BDTX-1535 for NSCLC treatment. Click here to find out why I rate BDTX stock a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback